- Daraxonrasib for Previously Treated RAS -Mutant Non–Small-Cell Lung Cancer The New England Journal of Medicine
- FDA approves landmark pancreatic cancer drug that's shown to improve survival WUSA9
- Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests ABC News - Breaking News, Latest News and Videos
- A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs The New York Times
- RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer BioSpace
Рекомендовані коментарі
Для публікації повідомлень створіть обліковий запис або авторизуйтесь